Combination therapy of type II anti-CD20 antibody and proteasome inhibitor

• 收藏
• 分享

专利权人:

ロシュ グリクアート アクチェンゲゼルシャフト

发明人:

フェルティヒ，ゲオルク,フリース，トマス,クライン，クリスティアン,ウマナ，パブロ,フェルティヒ,ゲオルク,フリース,トマス,クライン,クリスティアン,ウマナ,パブロ

申请号：

JP2010530330

公开号：

JP5469073B2

申请日:

2008.10.22

申请国别(地区):

JP

年份:

2014

代理人:

摘要：

The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a proteasome inhibitor for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type II anti-CD20 antibody and a proteasome inhibitor. Another aspect of the invention is a kit comprising a type II anti-CD20 antibody and a proteasome inhibitor. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type II anti-CD20 antibody and a proteasome inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/